News | October 24, 2007

Cordis Releases Next Generation Carotid Stent

October 25, 2007 - Cordis Corp. announced at TCT 2007 the U.S. and European launch of Cordis’s next generation carotid stent system, the PRECISE PRO RX Nitinol Self-Expanding Stent, designed to treat clogged neck arteries and enable more efficient manipulation of the catheter and guidewire during stenting procedures and better crossability.

The PRECISE PRO RX Stent provides physicians with a broader range of treatment options for patients with carotid artery disease. It is the lowest profile system approved in the U.S. and among the lowest available in Europe. The PRECISE Stent is a small, wire-mesh tube that props open the blocked artery and may be used in conjunction with Cordis’ ANGIOGUARD Rx Emboli Capture Guidewire System- a tiny, basket-like device designed to trap particles of plaque, blood clot, or other material that may be dislodged in the carotid artery during stent placement.

The PRECISE PRO RX Stent System is FDA and CE Mark approved to treat carotid artery disease in patients at high risk for adverse events from carotid endarterectomy (CEA) - a surgical treatment for removing arterial plaque from the carotid artery. The Cordis PRECISE Stent is the only carotid system backed by a large, randomized clinical trial - the landmark SAPPHIRE study - to support the potential benefits of carotid artery stenting (CAS) in patients who are ineligible, or considered high-risk, for carotid endarterectomy.

For more information: www.cordis.com

Related Content

InspireMD, CGuard embolic protection system, EPS, clinical data, internal carotid artery stenosis, ICA
News | Stents Carotid| November 18, 2016
November 18, 2016 — InspireMD Inc.
transcarotid artery revascularization, TCAR Surveillance Project, Society for Vascular Surgery Patient Safety Organization, SVS PSO,
News | Stents Carotid| October 13, 2016
A surveillance project to evaluate the safety and effectiveness of transcarotid artery revascularization (TCAR) in...
CREST trial results, New England Journal of Medicine, stenting, endarterectomy, carotid artery stenosis
News | Cath Lab| March 04, 2016
Recent results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) are evidence that...
carotid artery stenting, outcomes, JACC, Beau Hawkins, Robert Yeh, CARE Registry
Feature | Stents Carotid| July 13, 2015
Hospitals performing carotid artery stenting vary considerably in rates of in-hospital stroke or death, according to a...
News | Stents Carotid| June 17, 2015
Karam Moon, M.D., winner of the DePuy Synthes Cerebrovascular Section Resident/Fellow Award, presented his research,...
Technology | June 01, 2015
Silk Road Medical Inc. announced the company received U.S. Food & Drug Administration (FDA) 510(k) clearance for...
carotid artery stenting, F-EPD, P-EPD, ACC, embolic protection devices
News | April 22, 2015
A study published in JACC: Cardiovascular Interventions showed that in-hospital and 30-day stroke or death rates were...
VIVA, VIVA Physicians, Peripheral, Carotid Artery Device, clinical trial results
Feature | November 11, 2014
Viva Physicians, a not-for-profit organization in the field of vascular medicine and intervention, announce clinical...
Stenting Safe Effective Long-term Stroke Prevention
News | October 16, 2014
Using stents to keep neck arteries open is just as effective as invasive neck surgery for long-term prevention of fatal...
Overlay Init